These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29327220)

  • 21. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe.
    Graff MR; McClanahan MA
    Clin Ther; 1998; 20(3):486-96. PubMed ID: 9663364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a New Measure for Assessing Insulin Delivery Device Satisfaction in Patients with Type 1 and Type 2 Diabetes.
    Polonsky WH; Fisher L; Hessler D; Edelman SV
    Diabetes Technol Ther; 2015 Nov; 17(11):773-9. PubMed ID: 26167948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient Preferences and Health State Utilities Associated with Mealtime Insulin Concentrations Among Patients with Diabetes in Italy.
    Matza LS; Osumili B; Stewart KD; Perez-Nieves M; Jordan J; Biricolti G; Romoli E; Losi S; Del Santo S; Spaepen E; Parola G; Karn H; Boye KS
    Diabetes Ther; 2020 Jan; 11(1):319-330. PubMed ID: 31760598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laboratory and Benchtop Performance of a Mealtime Insulin-Delivery System.
    Dreon DM; Hannon TM; Cross B; Carter BJ; Mercer NS; Nguyen JH; Tran A; Melendez PA; Morales N; Nelson JE; Tan MH
    J Diabetes Sci Technol; 2018 Jul; 12(4):817-827. PubMed ID: 29488399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of patient-reported outcomes of insulin pen devices versus conventional vial and syringe.
    Molife C; Lee LJ; Shi L; Sawhney M; Lenox SM
    Diabetes Technol Ther; 2009 Aug; 11(8):529-38. PubMed ID: 19698067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initiating insulin therapy in type 2 diabetes: benefits of insulin analogs and insulin pens.
    Brunton S
    Diabetes Technol Ther; 2008 Aug; 10(4):247-56. PubMed ID: 18715198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings.
    Aronson R; Gibney MA; Oza K; Bérubé J; Kassler-Taub K; Hirsch L
    Clin Ther; 2013 Jul; 35(7):923-933.e4. PubMed ID: 23790553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Healthcare professional and patient assessment of a new prefilled insulin pen versus two widely available prefilled insulin pens for ease of use, teaching and learning.
    Nadeau DA; Campos C; Niemeyer M; Bailey T
    Curr Med Res Opin; 2012 Jan; 28(1):3-13. PubMed ID: 22114905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usability and preference assessment of a new prefilled insulin pen versus vial and syringe in people with diabetes, physicians and nurses.
    Campos C; Lajara R; Deluzio T
    Expert Opin Pharmacother; 2012 Sep; 13(13):1837-46. PubMed ID: 22873943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does pen help? A real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus.
    Xie L; Zhou S; Wei W; Gill J; Pan C; Baser O
    Diabetes Technol Ther; 2013 Mar; 15(3):230-6. PubMed ID: 23336845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient acceptance and issues of education of two durable insulin pen devices.
    Asakura T; Seino H; Jensen KH
    Diabetes Technol Ther; 2008 Aug; 10(4):299-304. PubMed ID: 18715204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin delivery by injection in children and adolescents with diabetes.
    Hanas R; de Beaufort C; Hoey H; Anderson B
    Pediatr Diabetes; 2011 Aug; 12(5):518-26. PubMed ID: 21481121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel pen-based Bluetooth-enabled insulin delivery system with insulin dose tracking and advice.
    Bailey TS; Stone JY
    Expert Opin Drug Deliv; 2017 May; 14(5):697-703. PubMed ID: 28359171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nurses' perceptions and satisfaction with the use of insulin pen devices compared with insulin vial and syringes in an inpatient setting.
    Shogbon AO; Ngo D; Jacob B; Kimble LP; Ryan G
    Diabetes Technol Ther; 2014 Nov; 16(11):742-6. PubMed ID: 25198537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ease of use and patient preference injection simulation study comparing two prefilled insulin pens.
    Clark PE; Valentine V; Bodie JN; Sarwat S
    Curr Med Res Opin; 2010 Jul; 26(7):1745-53. PubMed ID: 20482243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humalog(®) KwikPen™: an insulin-injecting pen designed for ease of use.
    Schwartz SL; Ignaut DA; Bodie JN
    Expert Rev Med Devices; 2010 Nov; 7(6):735-43. PubMed ID: 21050084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyads.
    Hey-Hadavi J; Pleil A; Deeb LC; Fuqua JS; Silverman LA; Reiner B; Newfield R; Rajicic N; Wajnrajch MP; Cara JF
    Clin Ther; 2010 Nov; 32(12):2036-47. PubMed ID: 21118739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient acceptance and reliability of new Humulin/Humalog 3.0 ml prefilled insulin pen in ten Croatian diabetes centres.
    Sucic M; Galic E; Cabrijan T; Ivandic A; Petrusic A; Wyatt J; Mincheva N; Milicevic Z; Malone J
    Med Sci Monit; 2002 Mar; 8(3):PI21-6. PubMed ID: 11884952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient and Physician Perspectives on Mode of Administration of the PCSK9 Monoclonal Antibody Alirocumab, an Injectable Medication to Lower LDL-C Levels.
    Roth EM; Bujas-Bobanovic M; Louie MJ; Cariou B
    Clin Ther; 2015 Sep; 37(9):1945-1954.e6. PubMed ID: 26278513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.